HemaSphere (Aug 2023)
S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY OF RECOMBINANT ADAMTS13 IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA
- Marie Scully,
- Jovanna Baptista,
- Indranil Bhattacharya,
- Spero Cataland,
- Paul Coppo,
- Loredana Cuccia,
- Tina Dutt,
- Shih-Han Susan Huang,
- Cristina Pascual Izquierdo,
- María Eva Mingot-Castellano,
- Aric Parnes,
- Katerina Pavenski,
- Kavitha Rajavel,
- Isidro Jarque,
- Linda T. Wang,
- Miguel Fernández Zarzoso,
- Andy Zhu,
- Björn Mellgård
Affiliations
- Marie Scully
- 1 Department of Haematology, University College London Hospitals, London, United Kingdom
- Jovanna Baptista
- 2 Takeda Development Center Americas, Inc., Cambridge, MA, United States
- Indranil Bhattacharya
- 2 Takeda Development Center Americas, Inc., Cambridge, MA, United States
- Spero Cataland
- 3 Department of Internal Medicine, Ohio State University, Columbus, OH, United States
- Paul Coppo
- 4 National Reference Center for Thrombotic Microangiopathy, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris and Sorbonne – Université (AP-HP.6), Paris, France
- Loredana Cuccia
- 2 Takeda Development Center Americas, Inc., Cambridge, MA, United States
- Tina Dutt
- 5 Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom
- Shih-Han Susan Huang
- 6 Department of Medicine, Western University, London, Ontario, Canada
- Cristina Pascual Izquierdo
- 7 Hospital General Universitario Gregorio Marañon, Instituto de Investigación Gregorio Marañon, Madrid, Spain
- María Eva Mingot-Castellano
- 8 Hematology Department, Hospital Universitario Virgen del Rocio, Instituto de Biomedicina, Sevilla, Spain
- Aric Parnes
- 9 Department of Medicine, Brigham and Women’s Hospital, Boston, MA, United States
- Katerina Pavenski
- 10 Departments of Laboratory Medicine and Medicine, St. Michael’s Hospital-Unity Health Toronto and Departments of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Canada
- Kavitha Rajavel
- 2 Takeda Development Center Americas, Inc., Cambridge, MA, United States
- Isidro Jarque
- 11 Hematology Department, Hospital La Fe, Valencia, Spain
- Linda T. Wang
- 2 Takeda Development Center Americas, Inc., Cambridge, MA, United States
- Miguel Fernández Zarzoso
- 12 Hematology Service, University Hospital Doctor Peset, Valencia, Spain
- Andy Zhu
- 2 Takeda Development Center Americas, Inc., Cambridge, MA, United States
- Björn Mellgård
- 2 Takeda Development Center Americas, Inc., Cambridge, MA, United States
- DOI
- https://doi.org/10.1097/01.HS9.0000968132.86513.06
- Journal volume & issue
-
Vol. 7
p. e8651306
Abstract
No abstracts available.